|
Volumn 455, Issue 7216, 2008, Pages 1029-
|
Does risk to humans justify high cost of fighting bovine TB?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
COST BENEFIT ANALYSIS;
COW;
DISEASE TRANSMISSION;
DRUG RESEARCH;
ECONOMIC ASPECT;
ERADICATION THERAPY;
HEALTH PROGRAM;
LETTER;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
MILK;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
OCCUPATIONAL HEALTH;
PASTEURIZATION;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROPHYLAXIS;
RISK FACTOR;
TUBERCULOSIS;
BOVINAE;
|
EID: 54549105437
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/4551029a Document Type: Letter |
Times cited : (16)
|
References (0)
|